Skip to main content
. 2017 Aug 8;7:164. doi: 10.3389/fonc.2017.00164

Figure 3.

Figure 3

Hematopoiesis-supporting potential of low-risk myelodysplastic syndromes (LR-MDS) and healthy controls (HC)-mesenchymal stromal cells (MSCs). BFU-E, CFU-G, and CFU-M isolated from healthy donors and LR-MDS were counted under a light microscope (A). Evaluation of mRNA expression of SDF-1 in LR-MDS MSC compared to HC (B). LR-MDS and HC-MSCs were cultured in adipogenic and osteogenic induction medium for 21 and 10 days, respectively, according to the protocol of the manufacturer. Then, the differentiation results were quantified by chemical staining (C). All experiments were performed in duplicate.